{"uuid": "a915cd38-ab54-07ca-df04-a5c7c3b1620a", "state": {"code": "confirmed", "et": "Kinnitatud", "en": "confirmed"}, "last_update": "2025-02-04T15:10:34", "title": {"en": "Pharmacology", "et": "Farmakoloogia"}, "credits": 6, "credit_type": "ECTS", "target": {"year": {"code": "2024", "et": "2024/2025", "en": "2024/2025"}, "semester": {"code": "spring", "et": "kevad", "en": "spring"}, "study_type": {"code": "fulltime", "et": "päevaõpe", "en": "regular studies"}, "language": {"code": "et", "et": "eesti keel", "en": "Estonian"}, "part": {"code": "2", "et": "2. osa", "en": "part 2"}, "part_credits": 6, "faculty": {"code": "MV", "name": {"en": "Faculty of Medicine", "et": "meditsiiniteaduste valdkond"}, "address": "Tartu linn, \nTartu linn, Tartumaa \nEST", "city": "Tartu linn", "level": 1, "academic": true, "supports_continuous_learning": true}, "course_main_structural_unit": {"code": "MVBS02", "name": {"en": "Department of Pharmacology", "et": "farmakoloogia osakond"}, "phone": "+372 737 4350", "webpage_url": "https://biomeditsiin.ut.ee/et/sisu/farmakoloogia-osakond", "address": "EST", "level": 3, "academic": true, "supports_continuous_learning": false, "parent_code": "MVBS"}, "label": {"en": "24/25 S regular part 2 6 CP MV", "et": "24/25 K PÕ 2. osa 6 EAP MV"}}, "general": {"year": {"code": "2024", "et": "2024/2025", "en": "2024/2025"}, "input_languages": [{"code": "et", "et": "eesti keel", "en": "Estonian"}], "structural_unit_shares": [{"structural_unit_code": "MVBS02", "structural_unit_name": {"en": "Department of Pharmacology", "et": "farmakoloogia osakond"}, "course_share_percent": 100, "coordinating": true}], "type": {"code": "regular", "et": "Tavaline aine", "en": "Regular course"}}, "additional_info": {"is_vota_course": true, "is_continuous_learning_course": false, "study_levels": [{"code": "bachelor_master", "et": "integreeritud bakalaureuse- ja magistriõpe", "en": "integrated bachelor's and master's studies"}], "hours": {"lecture": 21, "practice": 0, "seminar": 53, "colloquium": 0, "web_learning": 0, "independent_work": 82, "individual_work": 0, "internship": 0}, "prerequisites": [{"required": true, "uuid": "a0e8ddea-04ba-3188-46f5-5cad4af2e2c5", "code": "ARFS.01.063", "title": {"en": "Human Physiology", "et": "Inimese füsioloogia"}, "credits": 9, "state": {"code": "confirmed", "et": "Kinnitatud", "en": "confirmed"}, "last_update": "2024-02-05T11:04:36"}], "is_enlight_course": false}, "overview": {"study_languages": [{"code": "et", "et": "eesti keel", "en": "Estonian"}], "description": {"en": "During this course, the goals of the course will be explained in the initial lecture. Pharmacological terminology, types of receptors and drug specificity will be explained. The mechanisms underlying pharmacokinetics, which is the action of the body on the drug, will be explained. Pharmacokinetics includes drug absorption, distribution, metabolism (biotransformation) and excretion (ADME). Mechanisms underlying pharmacodynamics, which is the action of the drug on the body, will be taught. Pharmacodynamics includes the action of the drug on the cell, the system and the body bearing in mind that the action of the drug will also be affected by its pharmacokinetic profile. Exemplar drugs will be used to teach the principles of pharmacokinetics and pharmacodynamics. Principles guiding therapeutic drug use and the side-effects of the main groups of drugs will be explained. Dangerous side-effects of drugs, the general principles of cell damage and death, mutagenesis, carcinogenesis, teratogenicity and allergic reactions will be taught.", "et": "Kursuse käigus selgitatakse farmakoloogia ülesandeid ja põhimõisteid, retseptorite tüüpe ja ravimspetsiifilisust. Selgitatakse farmakokineetika põhilisi mehhanisme: ravimite imendumine, jaotumine, biotransformatsioon ja eritumine. Käsitletakse farmakokineetika mudeleid ja parameetreid. Selgitatakse farmakoloogilise vastusega ravimitele seotud mehhanisme, peamiste ravimirühmade farmakodünaamikat ja farmakokineetikat, kasutamisprintsiipe ja kõrvaltoimeid. Samuti käsitletakse ravimite ohtlikke kõrvaltoimeid, rakukahjustuse ja rakusurma üldisi printsiipe, mutageneesi, kartsinogeneesi, teratogeensust ja allergilisi reaktsioone."}, "objectives": [{"en": "The aim of the course is to provide basic knowledge on the main pharmacodynamic effects of drugs and groups of drugs. By the end of the course, the student will know how the primary pharmacodynamic effects of drugs are transformed into secondary pharmacodynamic effects and how drugs may be used in the treatment of diseases. The student will become familiar with pharmacokinetic properties of drugs and drug groups and how the pharmacokinetic properties of drugs determines their efficacy and toxicity. Students will become familiar with the side-effects and potential toxicities of the main groups of drugs, the mechanisms of their side-effects and principles to avoid these side-effects. The student will learn how to prescribe drugs according to the laws of the Estonian Republic.", "et": "Kursuse eesmärgiks on anda üliõpilastele baasteadmised põhiliste ravimite või ravimirühmade farmakodünaamilistest toimetest. Üliõpilane teab kursuse lõpetamisel, kuidas ravimite primaarne farmakodünaamiline reaktsioon transformeerub sekundaarseks reaktsiooniks ja kuidas seda kasutatakse haiguste ravis. Üliõpilane teab põhiliste ravimite farmakokineetilisi omadusi ja kuidas ravimi farmakokineetilised omadused määravad ravimite efektiivsuse ja toksilisuse. Üliõpilane teab põhiliste ravimite potentsiaalset toksilisust ja kõrvatoimeid, kõrvaltoimete mehhanisme ning nende vältimise printsiipe. Üliõpilane oskab välja kirjutada ravimeid retseptis vastavalt ravimiseadusele."}], "learning_outcomes": [{"en": "Students who have passed this course in basic Pharmacology will understand the basic principles of pharmacokinetics and pharmacodynamics and will have built up a base of knowledge on the mechanisms of actions of the most-used drugs, at the molecular and whole-organism level. Students will have learned about the most important groups of drugs and important representatives from each of these groups. For each of these representatives, the student will know the pharmacokinetic and pharmacodynamic properties, side-effects and the usefulness of the representative in treating particular pathologies. The student will have learned the mechanisms by which these representatives induce therapeutic effects and side effects and will have demonstrated knowledge on how to prevent or treat these side effects. The student will also have learned how to work with the scientific literature and will become capable of critically assessing published data in the field of pharmacology.\nAfter passing the course the student knows the main groups of drugs and the main pharmacological effects and side-effects of drugs, belonging to these groups.", "et": "Farmakoloogiakursuse I osa läbinud üliõpilane teab käsitletud ravimite põhirühmi ning rühmade tähtsamaid esindajaid. Üliõpilane teab farmakokineetika ja farmakodünaamika üldprintsiipe, tähtsamate ravimite toimeid ja toimemehhanisme nii molekulaarsel kui ka terve organismi tasandil. Üliõpilasel on iga ravimirühma esindaja kohta piisavalt teadmisi ravimi farmakokineetikast, farmakodünaamikast ning kõrvaltoimetest ja ta on võimeline põhjendama ravimi kasutamist teatud patoloogiliste seisundite korral. Üliõpilane teab, milliste mehhanismide kaudu avaldavad ravimid terapeutilist toimet ning kuidas ravimid võivad põhjustada kõrvaltoimeid ning oskab rakendada oma teadmisi kõrvaltoimete vältimiseks või korrigeerimiseks. Üliõpilane oskab töötada farmakoloogiaalase teadusliku kirjandusega ning on võimeline seda kriitiliselt analüüsima."}], "notes": {"et": "Seoses sellega, et vabariigis kehtestatud eriolukorra tõttu on auditoorse õppetöö toimumine kuni 30. aprillini 2020. a. keelatud, toimub õppetöö farmakoloogias veebipõhiselt. \n\nSeminaride materjalid sisestatakse Moodle keskkonda. Üliõpilastel on kohustus iseseisvalt läbi töötada Moodle keskkonnas antud teema kohta üles pandud materjal.\n\nLoengud toimuvad ettenähtud ajal ONLINE."}}, "grading": {"independent_work": {}, "independent_work_assessments": [{"work_type": {"code": "test", "et": "Kontrolltöö", "en": "test"}, "description": {"et": "Seminarideks on vajalik eelnev iseseisev töö, mille käigus üliõpilane viib end kurssi seminari temaatikaga ning tutvub käsitletava teema põhiaspektidega enne seminari. Kevadsemestril tuleb üliõpilastel igas seminaris sooritada kontrolltest seminaris käsitletavate teemade kohta. Kontrolltest koosneb valikvastustega testküsimusest ja/või lühiküsimusest. Seminariarvestuse saab juhul, kui üliõpilane sooritab kontrolltesti tulemusele 60% või enam maksimaalsest tulemusest.\nKontrolltesti hinnatakse järgmiselt:\n0-5,9 punkti - mittearvestatud\n6,0-10 punkti - arvestatud\nMittearvestatud kontrolltestid tuleb järelevastamiste nädalal uuesti vastata.\nKevadsemestril toimub 4 kirjalikku kontrolltööd. Kontrolltöö koosneb valikvastustega küsimustest, kirjalikest lühiküsimustest või situatsioonülesandest. Kokku saab kontrolltöö eest maksimaalselt 25 punkti.\nKontrolltööd hinnatakse vastavalt punktidele:\nA:  91 - 100%\nB:  81 - 90%\nC: 71 - 80%\nD: 61 - 70%\nE: 55 - 60%"}}, {"work_type": {"code": "written", "et": "Kirjalik lõpphindamine", "en": "final written assessment"}, "description": {"et": "Kirjalik lõpphindamine\nKirjalik eksam koosneb 100 valikvastustega küsimusest ja kirjalikest lühiküsimustest. Eksam sisaldab kogu farmakoloogia kursuse materjali (sügissemester ja kevadsemester).\nIga eksamiküsimus annab 1 punkti. Kokku saab eksamil maksimaalselt 100 punkti."}}], "grade_preconditions": {"et": "Kui mõni võlgnevus jääb likvideerimata, siis eksamile ei pääse ja eksamihindeks läheb F, ning tuleb sooritada järeleksam."}, "grade_evaluation": {"et": "Automaateksamit ei ole.\nLõpphinde kujunemisel läheb arvesse eksamitulemus."}, "debt_elimination": {"et": "Mittearvestatud kontrolltestid tuleb järelevastamiste nädalal uuesti vastata.  Kontrolltööde järelevastamine toimub semestri viimasel nädalal. Järelevastamisele saab tulla kõikidel päevadel ja kui esimene järelsooritus ebaõnnesub, saab tulla järgmisel ajal ja kontrolltöö või kontrolltesti uuesti sooritada. Nädala lõpuks peavad olema võlgnevused likvideeritud."}, "assessment_scale": {"code": "grade", "et": "Eristav (A, B, C, D, E, F, mi)", "en": "differentiated (A, B, C, D, E, F, not present)"}, "results_available_from": {}}, "resources": {"web_based": {"code": "2", "et": "põimõpe", "en": "blended learning"}, "website_url": "http://moodle.ut.ee", "is_moodle_connected": false, "recommended_materials": "1. H. P. Rang, M. M. Dale, J. M. Ritter, R. J. Flower , Rang and Dale, Pharmacology, Flower Churchill-Livingstone 2012\n2. T. Zharkovskaja, P. Pokk, A. Kalda, Farmakoloogia ülesanded, Tartu 2005"}, "participants": {"lecturers": [{"person_uuid": "3ed789e6-9735-0cc0-5a44-c51676875a5c", "person_name": "Allen Kaasik", "structural_unit": {"code": "MVBS02FT", "name": {"en": "Chair of Pharmacology and Toxicology", "et": "farmakoloogia ja toksikoloogia õppetool"}, "address": "EST", "level": 4, "academic": false, "supports_continuous_learning": false, "parent_code": "MVBS02"}, "is_responsible": false, "is_teaching": true}, {"person_uuid": "ba65b685-a0b6-8c44-d79c-eb128c78ccfb", "person_name": "Külli Jaako", "structural_unit": {"code": "MVBS02FT", "name": {"en": "Chair of Pharmacology and Toxicology", "et": "farmakoloogia ja toksikoloogia õppetool"}, "address": "EST", "level": 4, "academic": false, "supports_continuous_learning": false, "parent_code": "MVBS02"}, "is_responsible": true, "is_teaching": true, "study_group_roles": {"2. rühm": {"code": "1", "et": "Lektor", "en": "lecturer"}, "1. rühm": {"code": "1", "et": "Lektor", "en": "lecturer"}}}, {"person_uuid": "669285bf-6e50-bea8-a723-ea3c68a21626", "person_name": "Annika Vaarmann", "structural_unit": {"code": "MVBS02FT", "name": {"en": "Chair of Pharmacology and Toxicology", "et": "farmakoloogia ja toksikoloogia õppetool"}, "address": "EST", "level": 4, "academic": false, "supports_continuous_learning": false, "parent_code": "MVBS02"}, "is_responsible": false, "is_teaching": true, "study_group_roles": {"2. rühm": {"code": "3", "et": "Seminarijuhendaja", "en": "supervisor of seminar"}, "1. rühm": {"code": "3", "et": "Seminarijuhendaja", "en": "supervisor of seminar"}}}, {"person_uuid": "a9d60a0e-e357-583a-b54b-c62571406faf", "person_name": "Katrin Pruus", "structural_unit": {"code": "MVBS02FT", "name": {"en": "Chair of Pharmacology and Toxicology", "et": "farmakoloogia ja toksikoloogia õppetool"}, "address": "EST", "level": 4, "academic": false, "supports_continuous_learning": false, "parent_code": "MVBS02"}, "is_responsible": false, "is_teaching": true, "study_group_roles": {"2. rühm": {"code": "3", "et": "Seminarijuhendaja", "en": "supervisor of seminar"}, "1. rühm": {"code": "3", "et": "Seminarijuhendaja", "en": "supervisor of seminar"}}}, {"person_uuid": "783e3c04-4879-5cad-84b4-e50b1aaef9b8", "person_name": "Malle Kuum", "structural_unit": {"code": "MVBS02FT", "name": {"en": "Chair of Pharmacology and Toxicology", "et": "farmakoloogia ja toksikoloogia õppetool"}, "address": "EST", "level": 4, "academic": false, "supports_continuous_learning": false, "parent_code": "MVBS02"}, "is_responsible": false, "is_teaching": true, "study_group_roles": {"2. rühm": {"code": "3", "et": "Seminarijuhendaja", "en": "supervisor of seminar"}, "1. rühm": {"code": "3", "et": "Seminarijuhendaja", "en": "supervisor of seminar"}}}], "assistants": ["81c9b369-c85d-4855-01e1-78cf3c3cdc72"], "study_groups": [{"uuid": "4f30886d-a33f-6f42-5ea3-fbc2d918206e", "code": "1. rühm"}, {"uuid": "23080df7-0823-f8c3-db85-53b97c6c0524", "code": "2. rühm"}]}, "schedule": {"weeks": {}, "entries": [{"time": "2025-02-11", "work_type": {"code": "lecture", "et": "loeng", "en": "lecture"}, "topic": {}, "description": {"et": "Antidepressandid. Trankvillisaatorid ja uinutid"}}, {"time": "2025-02-12", "work_type": {"code": "seminar", "et": "seminar", "en": "seminar"}, "topic": {}, "description": {"et": "Psühhotroopsed ravimid: antidepressandid, trankvilliaatorid, uinutid"}}, {"time": "2025-02-14", "work_type": {"code": "lecture", "et": "loeng", "en": "lecture"}, "topic": {}, "description": {"et": "Antipsühhootikumid. Psühhostimulaatorid"}}, {"time": "2025-02-18", "work_type": {"code": "seminar", "et": "seminar", "en": "seminar"}, "topic": {}, "description": {"et": "Psühhotroopsed ravimid: psühhostimulaatorid, antipsühhootikumid, kannabinoidid, hallutsinogeenid"}}, {"time": "2025-02-19", "work_type": {"code": "seminar", "et": "seminar", "en": "seminar"}, "topic": {}, "description": {"et": "Epilepsiavastased ravimid. Lokaalanesteetikumid"}}, {"time": "2025-02-21", "work_type": {"code": "lecture", "et": "loeng", "en": "lecture"}, "topic": {}, "description": {"et": "Analgeetikumid"}}, {"time": "2025-02-26", "work_type": {"code": "seminar", "et": "seminar", "en": "seminar"}, "topic": {}, "description": {"et": "Opiodanalgeetikumid: (looduslikud, poolsünteetilised ja sünteetilised opioidid). Sõltuvuse teke ja opioidisõltuvuse ravi"}}, {"time": "2025-03-04", "work_type": {"code": "seminar", "et": "seminar", "en": "seminar"}, "topic": {}, "description": {"et": "Ühisseminar ruumides 0088-0089"}}, {"time": "2025-03-05", "work_type": {"code": "seminar", "et": "seminar", "en": "seminar"}, "topic": {}, "description": {"et": "Analgeetikumid: MSPVA-d"}}, {"time": "2025-03-07", "work_type": {"code": "lecture", "et": "loeng", "en": "lecture"}, "topic": {}, "description": {"et": "Hingamisteede farmakoloogia"}}, {"time": "2025-03-11", "work_type": {"code": "seminar", "et": "seminar", "en": "seminar"}, "topic": {}, "description": {"et": "Põletikuvastased ravimid: Glükokortikosteroidid.\nNeurodegeneratiivsete haiguste (Parkinsoni tõbi, Alzheimeri tõbi) ravi"}}, {"time": "2025-03-12", "work_type": {"code": "test", "et": "kontrolltöö", "en": "test"}, "topic": {}, "description": {"et": "Kontrolltöö: psühhofarmakoloogia, valu ja põletiku korral kasutatavad ravimid, neurodegeneratiivsete haiguste korral kasutatavad ravimid"}}, {"time": "2025-03-14", "work_type": {"code": "lecture", "et": "loeng", "en": "lecture"}, "topic": {}, "description": {"et": "Seedetrakti farmakoloogia"}}, {"time": "2025-03-18", "work_type": {"code": "seminar", "et": "seminar", "en": "seminar"}, "topic": {}, "description": {"et": "Hingamisteedesse toimivate ravimite farmakoloogia"}}, {"time": "2025-03-19", "work_type": {"code": "seminar", "et": "seminar", "en": "seminar"}, "topic": {}, "description": {"et": "Seedetrakti farmakoloogia"}}, {"time": "2025-03-24", "work_type": {"code": "lecture", "et": "loeng", "en": "lecture"}, "topic": {}, "description": {"et": "Suguhormoonid"}}, {"time": "2025-03-26", "work_type": {"code": "seminar", "et": "seminar", "en": "seminar"}, "topic": {}, "description": {"et": "Suguhormoonid. Kilpnäärmehormoonid (lühidalt)"}}, {"time": "2025-03-31", "work_type": {"code": "lecture", "et": "loeng", "en": "lecture"}, "topic": {}, "description": {"et": "Suhkurtõve farmakoloogia"}}, {"time": "2025-04-02", "work_type": {"code": "seminar", "et": "seminar", "en": "seminar"}, "topic": {}, "description": {"et": "Diabeedivastased ravimid"}}, {"time": "2025-04-07", "work_type": {"code": "e-learning", "et": "e-õpe", "en": "e-learning"}, "topic": {}, "description": {"et": "Viirusevastased ravimid (e-loeng)"}}, {"time": "2025-04-09", "work_type": {"code": "test", "et": "kontrolltöö", "en": "test"}, "topic": {}, "description": {"et": "Kontrolltöö: seedetrakti, hingamisteede, sukrutõve, sugu- ja kilpnäärmehormoonide farmakoloogia"}}, {"time": "2025-04-14", "work_type": {"code": "lecture", "et": "loeng", "en": "lecture"}, "topic": {}, "description": {"et": "Antibiootikumid (AB kasutamise põhiprintsiibid, beetalaktaamantibiootikumid"}}, {"time": "2025-04-15", "work_type": {"code": "seminar", "et": "seminar", "en": "seminar"}, "topic": {}, "description": {"et": "Immuunsust mõjutavad ravimid: immunosupressandid, immunomodulaatorid. Viirusevastased ravimid"}}, {"time": "2025-04-21", "work_type": {"code": "lecture", "et": "loeng", "en": "lecture"}, "topic": {}, "description": {"et": "Antibiootikumid: laia toimespektriga AB-d"}}, {"time": "2025-04-22", "work_type": {"code": "seminar", "et": "seminar", "en": "seminar"}, "topic": {}, "description": {"et": "Antibiootikumid I: antibiootikumide kasutamise printsiibid. Sulfoonamiidid. Beetalaktaamantibiootikumid"}}, {"time": "2025-04-23", "work_type": {"code": "seminar", "et": "seminar", "en": "seminar"}, "topic": {}, "description": {"et": "Antibiootikumid II: tetratsükliinid, amfenikoolid, aminoglükosiidid, kinoloonid, imidasooli derivaadid, nitrofuraani derivaadid jt"}}, {"time": "2025-04-28", "work_type": {"code": "lecture", "et": "loeng", "en": "lecture"}, "topic": {}, "description": {"et": "Kasvajavastased ravimid (e-loeng)"}}, {"time": "2025-04-29", "work_type": {"code": "seminar", "et": "seminar", "en": "seminar"}, "topic": {}, "description": {"et": "Tuberkuloosivastased ravimid, seenevastased ravimid"}}, {"time": "2025-04-30", "work_type": {"code": "seminar", "et": "seminar", "en": "seminar"}, "topic": {}, "description": {"et": "Kasvajavastased ravimid"}}, {"time": "2025-05-07", "work_type": {"code": "test", "et": "kontrolltöö", "en": "test"}, "topic": {}, "description": {"et": "Kontrolltöö: kemoterapeutikumid"}}, {"time": "2025-05-14", "work_type": {"code": "seminar", "et": "seminar", "en": "seminar"}, "topic": {}, "description": {"et": "Võlgnevuste likvideerimine (kokku 3 korda, üks kord kokkuleppel semestri keskel ja kaks aega semestri viimasel nädalal)"}}]}, "registration_info": {"audience": {}, "min_students": 5}, "parent_uuid": "c6193e61-ba7a-08ea-a283-98211618f47b", "parent_code": "ARFR.02.051", "parent_credits": 11, "_actions": {"is_moodle_editable": false, "is_editable": false, "is_deletable": false}}